Bio Plus Co., Ltd (KOSDAQ:099430)

Market Cap	413.27B
Revenue (ttm)	79.78B
Net Income (ttm)	19.60B
Shares Out	58.87M
EPS (ttm)	330.29
PE Ratio	21.25
Forward PE	n/a
Dividend	50.00 (0.71%)
Ex-Dividend Date	Dec 27, 2024

Volume	360,414
Average Volume	641,898
Open	6,980.00
Previous Close	7,020.00
Day's Range	6,880.00 - 7,150.00
52-Week Range	4,250.00 - 8,420.00
Beta	0.60
RSI	38.94
Earnings Date	May 15, 2025

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099430

Financial Performance

In 2024, Bio Plus's revenue was 66.41 billion, an increase of 2.10% compared to the previous year's 65.04 billion. Earnings were 14.15 billion, a decrease of -44.68%.